申请人:BANYU PHARMACEUTICAL CO., LTD.
公开号:EP1557418A1
公开(公告)日:2005-07-27
A quinoxalinone derivative of the formula (I):
or a pharmaceutically acceptable salt or ester thereof, wherein;
X is NH, S or the like;
Y is O or the like;
the partial structure
is, for example, the formula:
B1, B2, ....., Bn-1 and Bn, (in which n is 4 , 5 or 6) are each independently CH, N or the like;
B'1, B'2, ....., B'n-1 and B'n (in which n is 4, 5 or 6) are each independently hydrogen or the like; and
R is hydrogen, lower alkyl or the like.
式(I)的喹喔啉酮衍生物:
或其药学上可接受的盐或酯,其中
X 是 NH、S 或类似物
Y 是 O 或类似物;
部分结构
例如为式
B1、B2、.....、Bn-1 和 Bn,(其中 n 为 4、5 或 6)各自独立地为 CH、N 或类似物;
B'1、B'2、.....、B'n-1 和 B'n(其中 n 为 4、5 或 6)各自独立地为氢或类似物;以及
R 是氢、低级烷基或类似物。